Myomo, INC Schedule 13G passive stakes

Rosalind Advisors, Inc. and its affiliates have jointly filed a Schedule 13G/A, reporting a beneficial ownership of 9.9% of Myomo, Inc.'s common stock.

Rosalind Advisors and Master Fund confirm a passive beneficial ownership of approximately 9.99% in Myomo, Inc., primarily through common stock and pre-funded warrants subject to blocker provisions.

Rosalind Advisors and affiliated entities filed an amended Schedule 13G/A for Myomo, Inc., clarifying beneficial ownership of 3,790,788 common shares, representing 9.99% due to warrant blocker provisions.

Orin Hirschman and AIGH Capital Management LLC have filed an amended Schedule 13G, disclosing beneficial ownership of 1.3% of Myomo, Inc.'s common stock.

Rosalind Advisors and affiliated entities have filed an amended Schedule 13G/A, disclosing their beneficial ownership in Myomo, Inc. at 9.51% of common stock.

Rosalind Advisors, Inc., Rosalind Master Fund L.P., Steven Salamon, and Gilad Aharon have filed an amended Schedule 13G/A, disclosing a 9.9% beneficial ownership stake in Myomo, Inc., though blocker provisions prevent immediate exercise of pre-funded warrants that would push ownership above 9.99%.

AIGH Capital Management LLC and Orin Hirschman have jointly disclosed a beneficial ownership of 3,381,567 shares, representing 9.9% of Myomo, Inc.'s common stock, as of December 31, 2024.

Rosalind Advisors, Inc. and its affiliates have filed an amended Schedule 13G/A, disclosing a continued beneficial ownership of Myomo, Inc. common stock, including pre-funded warrants subject to a 9.99% ownership blocker.